Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

समान संसाधन

• Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
  द्वारा: MacNeil, Jessica R., और अन्य
  प्रकाशित: (2021)
• The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021
  द्वारा: Wallace, Megan, और अन्य
  प्रकाशित: (2021)
• Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
  द्वारा: Meites, Elissa, और अन्य
  प्रकाशित: (2019)
• The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
  द्वारा: Oliver, Sara E., और अन्य
  प्रकाशित: (2021)
• Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
  द्वारा: Petrosky, Emiko, और अन्य
  प्रकाशित: (2015)